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Abstract—Heart failure (HF) is one of the major health concerns 
worldwide due to high incidence and mortality. HF patients 
experience high level of psychological distress, particularly 
anxiety and depression. To increase survival rate, implantable 
cardioverter defibrillator (ICD) acts as a life-savor to deliver 
immediate shock to correct life-threatening arrhythmias as HF 
patients are the high-risk population for sudden cardiac arrest. It 
was attributed to unpredictable ICD shock. Moreover, some 
studies reported that ICD can improve health-related quality of 
life (HRQoL) among HF patients. However, ICD was evidenced 
to increase anxiety and depression. Psychological distress can 
also impair HRQoL of ICD patients. Due to different health 
conditions and health needs, ICD patients with and without HF 
can perceive different degrees of heightened psychological 
distress and declined HRQoL. Although the number of HF 
patients receiving ICD implantation has been increasing, 
inadequate knowledge is reported about their psychological 
status and HRQoL. To improve current ICD care to patients 
with and without HF, this study aimed to compare psychological 
status (anxiety and depression) and HRQoL and identify the 
relationships of personal and clinical characteristics with 
psychological status and HRQoL between ICD patients with and 
without HF. A total of 139 ICD patients were recruited, including 
68 patients with HF. Those with HF perceived relatively higher 
depression and poorer physical HRQoL. Patients without HF 
who were married perceived better physical and mental health. 
Patients with HF who were more dependent have heightened 
anxiety and depression. The results shed light on the differences 
from the level of anxiety and depression among ICD patients 
with and without HF as well as their HRQoL so that ICD care 
for these two specific ICD patient groups can be directed. Family 
involvement is more significant for patients with and without HF. 
Keywords- Implantable cardioverter defibrillator, heart failure, 
psychological distress, health-related quality of life 
I. INTRODUCTION 
Heart failure (HF) is one of the major cardiac problems 
with higher rates of incidence and mortality from sudden 
cardiac death (SCD) worldwide [1-3]. In the US, an estimated 
projection of HF cases was increased by 46% from 2012 to 
2030 [2]. About 50% of HF patients will die within five years 
of diagnosis [4]. To increase survival rate, implantable 
cardioverter defibrillator (ICD) has been a favourable medical 
treatment to reduce mortality by delivering immediate ICD 
shock to restore normal heart rhythms [5,6]. Currently, an ICD 
device, called cardiac resynchronization therapy defibrillator 
(CRT-D), can provide two specific functions, anti-tachycardia 
pacing (ATP) and cardiac resynchronization therapy (CRT). 
ATP aims to reduce inappropriate shocks and CRT helps 
stimulate both ventricles to contract simultaneously to improve 
cardiac performance [7-9]. Therefore, the demand of HF 
patients receiving ICD has been increasing. As current health 
care emphasizes much on optimal health-related quality of life 
(HRQoL) that is beneficial to reduce demand of medical cost 
in treatment and rehabilitation, to prolong survival, and to 
shorten the hospitalization period [2,3], studies have been 
examining HRQoL in ICD patients. However, contradictory 
results were reported. Some studies reported that ICD patients 
perceived poorer HRQoL, particularly in physical aspects due 
to the possibility of ICD shock occurrence [10-13]. Studies 
were also conducted to examine HRQoL in patients with HF. 
Physical function was commonly affected in those patients 
[10,11]. Since HF patients are commonly reported to have 
poorer HRQoL, particularly physical health, due to insufficient 
cardiac function, ICD patients with HF will have double-folded 
physical restriction and disability due to inadequate cardiac 
function [10,14-15]. Eventually, those patients cannot maintain 
their daily activities of living and their ability of self-care 
declines [10,14]. However, knowledge about the effects of ICD 
on HRQoL among HF patients is still insufficient and 
inconsistent. Knackstedt and colleagues [16] reported that 
patients receiving ICD with or without CRT had no differences 
on HRQoL. 
Anxiety and depression are commonly found in both HF 
patients [17,18] and ICD patients [14,19]. These two emotions 
can poorly affect the patient’s health condition [12,13,20-22] 
and are closely linked to higher mortality in cardiac patients 
[23,24]. Anxiety and, particularly, depression are important 
markers for cardiac diseases and high mortality [24,25]. 
Despite its main function in mortality reduction, ICDs were 
reported to bring heightened psychological distress to patients 
[26-28]. The past studies reported that about 24-33% of ICD 
patients perceived high level of depression and estimated 9-
15% of them had clinically significant depression [29,30]. 
Since HF patients receiving ICD have been numbering, their 
anxiety and depression and associated factors can be different 
from those of patients without HF.  
To provide appropriate care for ICD patients with or 
without HF having different health needs, the study aimed to 1) 
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to compare psychological distress (anxiety and depression) and 
HRQoL between ICD patients with and without HF and 2) to 
identify relationships of demographic and clinical 
characteristics with psychological status and HRQoL. The 
results are useful to direct ICD care for improving HRQoL and 
reducing anxiety and depression with consideration of 
demographic and clinical factors between these two ICD 
specific groups. 
II. METHODS
A secondary analysis was performed to further understand 
factors associated with psychological distress (anxiety and 
depression) and HRQoL of ICD patients with and without HF 
to understand better the direction to develop special care for 
ICD patients with and without HF. 
A. Design and sampling
A cross-sectional questionnaire survey was conducted
using convenience sampling. Patients were recruited at two 
hospitals when they 1) were Chinese adults (≥18 years old); 2) 
were ICD recipients with HF; 3) were able to communicate in 
Chinese; and 4) had no cognitive problems  
B. Data collection
All eligible subjects were requested to sign an informed
consent and then fill in one set of questionnaires, including the 
demographic and clinical form, the Chinese-Cantonese version 
of the Hospital Anxiety and Depression Scale (HADS) and the 
Chinese (Hong Kong) version of the Medical Outcomes Study 
36-Item Short-Form Health Survey (SF-36v2) via face-to-face 
interview. ICD data were obtained from medical records of 
patients. The interview took about 20 minutes. 
The SF-36v2 was also widely used to measure HRQoL 
outcomes. It consists of eight subscales and two component 
summary scores. The higher scores the better perceived 
HRQoL level [31]. The Cronbach’s alphas of the eight 
domains of SF-36v2 ranged from 0.78 to 0.98 in this study. 
The HADS is a widely used tool for depression and 
anxiety. It consists of 7 items for depression and 7 items for 
anxiety using 4-point Likert scale ranging from 0 (absence of 
symptoms) to 3 (severe symptoms). The total scores for each 
subscale range from 0 to 21 and the overall score ranges from 0 
to 42. A cut-off score of ≥8 for each subscale indicates 
clinically significant levels of depression and anxiety [32]. The 
HAD-A, HAD-D, and overall HADS indicated good reliability 
with the Cronbach’s alphas 0.75, 0.76, and 0.83, respectively. 
III. ETHICAL CONSIDERATIONS
Ethical approval was sought by the School Research 
Committee of the educational institution. All subjects were 
assured that they could withdraw from the study without 
consequences at any time. All information was anonymous for 
personal confidentiality. 
IV. DATA ANALYSIS
Data were analyzed using the IBM SPSS v20.0 0 (IBM 
Corporation, Armonk, New York, USA). Descriptive statistics 
were performed to summarize independent variables (patients’ 
demographics, HADS subscales, anxiety and depression) for 
ICD patients with and without HF. Univariate analyses were 
used to assess the relationships between independent variables 
and, depression level and anxiety level using Pearson’s 
correlation coefficient, independent-samples t-test, or one-way 
ANOVA between two ICD patient groups. All statistical tests 
involved were two-sided. The type I error rate (level of 
significance) was set at 0.05. 
V. RESULTS
A total of 139 ICD patients were recruited, including 68 
patients with HF (~50%).  
A. Demographic charcteristics
Their mean age was 64.24±12.35 years old.  There were 53
males (~78%) and 52 (76.5%) married and living with family. 
Most of the ICD patients with HF (n=64; 94.1%) were self-
care independent.  
About 30-40% of ICD patients with HF had comorbidities 
such as coronary artery disease (CAD), hypertension (HT), 
atrial fibrillation (AF), and diabetes mellitus (DM). Compared 
to ICD patients without HF, those with HF had relatively more 
comorbidities.  
Regarding ICD-related characteristics, 64.7% of ICD 
patients with HF received CRT-D. However, 5 ICD patients 
without HF (7%) had ICD shock experience and 3 (4.2%) had 
more than one ICD shock experience. This was a higher rate as 
compared to those with HF. 
Table I shows the details of demographic and clinical 
characteristics of the ICD patients with and without HF.  
TABLE I.  DEMOGRAPHIC AND CLINICAL 
CHARACTERISTICS 
Demographic characteristics 
ICD only (n=71) ICD with HF (n=68) 
Mean (SD) / n (%) Mean (SD) / n (%) 
Age (years)  59.01 (15.47) 64.24 (12.35) 
≥60 years old 43 (60.5) 54 (79.40) 
Male 54 (76.1) 53 (77.9) 
Married / cohabiting 55 (77.5) 52 (76.5) 
Self-care independence 67 (94.4) 64 (94.1) 
Educational level 
  Primary or below 27 (38.0) 30 (44.1) 
  Secondary or above 44 (62.0) 16 (45.7) 
Retired / unemployed 45 (63.4) 58 (85.3) 
Clinical characteristics 
Hypertension (HT) 18 (25.4) 27 (39.7) 
Hyperlipidemia 6 (12.8) 26 (38.2) 
Ischemic heart disease (IHD) 24 (33.8) 33 (48.5) 
Atrial fibrillation (AF) 13 (18.3) 21 (30.9) 
Diabetes mellitus (DM) 12 (16.9) 25 (36.8) 
Chronic obstructive airway 
disease (COAD) 
3 (4.2) 6 (8.8) 
ICD-related characteristics 
CRT-D 6 (8.5) 44 (64.7) 
Implantation period (years)  3.79 (1.37) 3.51 (1.31) 
Implantation period >12 
month 
58 (81.7) 52 (76.5) 
First timer of implantation 54 (76.1) 56 (82.4) 
With ICD shock experience  5 (7.0) 3 (4.4) 
Frequency of ICD shock 
Once 2 (2.8) 2 (2.9) 
≥ Twice 3 (4.2) 1 (1.5) 
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Data marked with  are presented as mean (standard deviation), 
whereas the others are presented as frequency (%). 
B. HRQoL between ICD patients with and without heart 
failure (Table 2) 
Based on the subscales of SF-36v2, the scores of physical 
functioning (PF) and vitality (VIT) were found to have relative 
large differences between ICD patients with and without HF 
(PF: mean 67.57±28.20 vs mean 75.07±24.92, respectively; 
VIT: mean 48.44±29.56 vs mean 60.56±28.16, respectively). 
Moreover, the PCS score was lower in ICD patients with HF 
compared to those without HF (mean 37.84±14.94 vs mean 
41.36±13.92, respectively). 
 
TABLE II.  HEALTH-RELATED QUALITY OF LIFE BETWEEN    
ICD PATIENTS WITH AND WITHOUT HEART FAILURE 
Health-related quality of life 
[SF-36v2] 
ICD without HF 
(n=71) 
ICD with HF 
(n=68) 
Mean (SD) / n (%) Mean (SD) /n (%) 
Physical functioning subscale  75.07 (24.92) 67.57 (28.20) 
Role physical subscale  71.57 (37.47) 67.28 (35.60) 
Bodily pain subscale  83.46 (23.91) 86.51 (23.42) 
General health subscale  50.65 (28.56) 49.54 (24.62) 
Vitality subscale  60.56 (28.16) 48.44 (29.56) 
Social functioning subscale  89.96 (23.11) 89.34 (22.47) 
Role emotional subscale  88.62 (22.72) 91.67 (21.79) 
Mental health subscale  76.48 (22.05) 78.09 (20.75) 
Physical component summary 
(PCS)  
41.36 (13.92) 37.84 (14.94) 
Mental component summary  
(MCS) 55.76 (10.93) 55.96 (9.92) 
Data marked with  are presented as mean (standard deviation), 
whereas the others are presented as frequency (%). 
 
C. Psychological status between ICD patients with and 
without heart failure (Table 3) 
Among the 68 ICD patients with HF, 11.80% of them 
(n=8) had significant levels of anxiety (HADS-A ≥8) and 
22.1% of them (n=15) reported significant levels of depression 
(HADS-D ≥8). The mean scores of HADS-D and HADS-A 
were 4.15 (SD=3.78) and 3.26 (SD=3.74) respectively. 
Among the 71 ICD patients without HF, 16.90% of them 
(n=12) had significant levels of anxiety and 18.3% of them 
(n=13) reported significant levels of depression. The mean 
scores of HADS-D and HADS-A were 4.23 (SD=4.08) and 
3.59 (SD=3.52), respectively. 
 
TABLE III.  PSYCHOLOGICAL STATUS BETWEEN ICD  
                           PATIENTS WITH AND WITHOUT HEART FAILURE 
 
 ICD without HF 
(n=71) 
ICD with HF (n=68) 
Mean (SD) / n (%) Mean (SD) / n (%) 
HADS-Depression: 
(Score ≥8) 
13 (18.3) 15 (22.1) 
HAD-Anxiety:  
(Score ≥8) 
12 (16.9) 8 (11.8) 
HADS-Depression  4.23 (4.08) 4.15 (3.78) 
HADS-Anxiety  3.59 (3.52) 3.26 (3.74) 
HADS overall 7.82 (6.65) 7.41 (6.72) 
Data marked with  are presented as mean (standard deviation) 
Relationships of HRQoL with demographic and clinical 
characteristics between ICD patients with and without HF 
(Table 4) 
 
The results showed that education (γ=0.39, p=0.001), 
being married (γ=0.25, p=0.033), self-care independence 
(γ=0.32, p=0.007), and occupation (γ=0.33, p=0.005) had 
positive relationships, while old age (≥60 years old) (γ= -0.31, 
p=0.008), having AF (γ= -0.32, p=0.007), and receiving CRT-
D (γ= -0.25, p=0.040) had negative relationships with PCS 
among ICD patients without HF. Whereas being married (γ= 
0.34, p=0.004) and having IHD (γ= 0.30, p=0.011) had 
negative correlations with MCS among ICD patients without 
HF. 
 
Among ICD patients with HF, education (γ=0.33, 
p=0.007), occupation (γ=0.33, p=0.006), and self-care 
independence (γ=0.36, p=0.002) had positive relationships, 
but old age (≥60 years old) (γ= -0.34, p=0.004) and having 
DM (γ= -0.34, p=0.005) had negative correlations with PCS. 
However, there were no variables correlated with MCS.  
 
TABLE IV.  RELATIONSHIPS OF HRQoL AND 
PSYCHOLOGICAL DISTRESS (ANXIETY AND DEPRESSION) 
BETWEEN ICD PATIENTS WITH AND WITHOUT HF 
 
 
PCS MCS 
Pearson 
correlation 
p 
Pearson 
correlation 
p 
ICD without HF (n=71) 
≥60 years old -0.31 0.008   
Education 0.39 0.001   
Being married 0.25 0.033 0.34 0.004 
Self-care 
independence 
0.32 0.007   
Occupation 0.33 0.005   
Having IHD   0.30 0.011 
Having AF -0.32 0.007   
Receiving 
CRT-D 
-0.25 0.040   
ICD with HF (n=68) 
 
Pearson 
correlation 
p 
Pearson 
correlation 
p 
≥60 years old -0.34 0.004   
Education 0.33 0.007   
Self-care 
independence 
0.36 0.002   
Occupation 0.33 0.006   
Having DM -0.34 0.005   
D. Relationships of psychological stress (anxiety and 
depression)  with demographic and clinical characteristics 
between ICD patients with and without HF (Table 5) 
 
The results showed that old age (≥60 years old) (γ=0.27, 
p=0.022), having COAD (γ=0.28, p=0.017), and receiving 
CRT-D (γ=0.33, p=0.004) had positive relationships, but 
being married (γ=-0.30, p=0.013), education (γ=-0.28, 
p=0.019), and occupation (γ=0.24, p=0.046) had negative 
relationships with depression among ICD patients without HF. 
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Whereas only having IHD (γ=-0.28, p=0.017) had negative 
correlation with anxiety among ICD patients without HF. 
Among ICD patients with HF, old age (≥60 years old) 
(γ=0.24, p=0.046) and having DM (γ=0.30, p=0.012) had 
positive correlations, but education (γ=-0.25, p=0.040) and 
self-care independence (γ=-0.31, p=0.011) had negative 
correlations with depression. Whereas self-care independence 
(γ=-0.27, p=0.027) had negative correlation with anxiety.  
 
TABLE V.  RELATIONSHIPS OF PSYCHOLOGICAL 
DISTRESS (ANXIETY AND DEPRESSION) BETWEEN ICD PATIENTS 
WITH AND WITHOUT HF 
 
 
Anxiety Depression 
Pearson 
correlation 
p 
Pearson 
correlation 
p 
ICD without HF (n=71) 
≥60 years old   0.27 0.022 
Education   -0.28 0.019 
Being married   -0.30 0.013 
Occupation   -0.24 0.046 
IHD -0.28 0.017   
COAD   0.28 0.017 
Receiving 
CRT-D 
  
0.33 0.004 
ICD with HF (n=68) 
 
Pearson 
correlation 
p 
Pearson 
correlation 
p 
≥60 years old   0.24 0.046 
Education   -0.25 0.040 
Self-care 
independence 
-0.27 0.027 -0.31 0.011 
DM   0.30 0.012 
 
VI. DISCUSSION 
This study results addressed the aims to understand the 
HRQoL and psychological status between ICD patients with 
and without HF as well as their relationships with patients’ 
demographic and clinical characteristics. The results revealed 
that ICD patients with HF were relatively older than those 
without HF. It also explained why those with HF were more 
likely to have more comorbidities. Those patients had 
relatively poorer cardiac conditions and hence they were more 
likely to receive CRT-D to optimize their wellbeing for normal 
daily activities by improving overall cardiac performance [7-
9].  
Based on the results of HRQoL, ICD patients with HF had 
poorer physical health probably due to their poor cardiac 
conditions. Although most of the HF patients had received 
CRT-D, there was no data related to physical wellbeing before 
implantation to understand more about the effects of CRT-D 
on physical health. Nevertheless, the mental health was 
comparable between the two groups. 
The levels of anxiety and depression were comparable 
between patients with HF and those without. However, a 
higher percentage of anxiety at clinically significant level 
(score ≥8) yet a lower percentage of depression at clinically 
significant level (score ≥8) were found in patients without HF 
than those with HF. The higher level of anxiety was found in 
those without HF most probably due to unpredictable ICD 
shocks and new adaptation to live with the device. Although 
ICD acts as a lifesaver, its shock is unpredictable and can 
induce physical pain [26,33]. Therefore, those who had 
experienced ICD shock would perceive more anxiety [34]. A 
higher frequency of ICD shock was found in patients without 
HF; hence, they might feel more anxious. Nevertheless, more 
patients with HF perceiving higher level of depression could be 
due to poor cardiac conditions [13,22,27,40] and limited 
physical activity [35,36].   
Moreover, diversities of demographic and clinical 
characteristics were found to be correlated with HRQoL 
(physical and mental) and psychological distress (anxiety and 
depression) between two ICD patient groups. It is important for 
healthcare professionals to pay close attention to specific ICD 
patients with different health needs, in particular those who 
have comorbidities, to reduce psychological distress and 
optimize both physical and mental HRQoL. Patients without 
HF who are of older age (≥60 years old), undereducated, 
retired/unemployed, unmarried, more dependent, diagnosed 
with AF, or implanted with conventional ICD will be more 
likely to have poor physical health and ability. Old age may 
affect physical activity due to decreased muscle tone and 
limited physical tolerance [37,38]. Retirement or 
unemployment was found to affect physical health; it could be 
due to old age and altered general health conditions. Patients 
who are married will have more support and assistance from 
family, leading to better physical health. Patients with AF or 
received conventional ICD indicate poorer health conditions, 
leading to further deterioration of physical wellbeing [13]. AF 
lowers cardiac output, resulting in physical intolerance. 
Patients receiving conventional ICD have poorer physical 
health probably because they have to adapt to living with the 
device [39] and have to limit some physical activities to avoid 
inappropriate shocks. Moreover, patients without HF who are 
married and have a history of IHD will have better mental 
health. It can be explained by the fact that married patients can 
receive psychological support from their families. Patients with 
a history of IHD perceive better mental health probably due to 
their previous heart attack(s) and receiving ICD as a lifesaver. 
It is important to note that patients without HF who are married 
will have better physical and mental health most probably due 
to family involvement in their recovery.  
Considering the physical health among ICD patients with 
HF, those who were older (≥60 years old), undereducated, 
retired/unemployed, more dependent, and diagnosed with DM 
had poorer physical health [13]. Patients with HF who are of 
older age face further deterioration of physical health due to 
insufficient cardiac function. ICD patients with HF have poorer 
physical health most probably due to poorer cardiac function, 
leading to poorer physical ability and tolerance [22,40,41]. 
Those who need more assistance and dependence for daily 
activities have poorer physical ability [41,42]. Adequate 
support is crucial to ICD patients as they need to adapt to 
living with their device. ICD patients with HF need more 
support and assistance from their families as their poor cardiac 
function reduces their physical ability, implying that they 
require more dependence on others to maintain their daily 
activities [41,43,44]. Those with DM suffer from physical 
intolerance probably due to insufficient insulin to regulate 
blood glucose level [13]. However, there were no demographic 
and clinical characteristic found to be correlated with mental 
health among patients with HF. It is important to note that 
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patients with HF will have more concerns about their physical 
health and ability. 
  Among ICD patients without HF, those who had a history 
of IHD perceived less anxiety. The reason may be that those 
patients have had previous experience of heart attack(s) and 
they have had more confidence in their ICD for protecting 
them from life-threatening episodes. More importantly, ICD 
patients without HF who are of older age (≥60 years old), 
undereducated, unmarried, retired or unemployed, had a 
history of COAD, or received CRT-D perceive more 
depression. Patients who are of older age (≥60 years old) are 
more likely to be retired. Older ICD patients without HF have 
more depression, perhaps due to their deteriorated general 
health [45-47], reduced physical ability, reduced ability for 
self-care, and role changes [33,41,42,48,49]. Due to their 
unfavorable cardiac condition, they may need to have early 
retirement. In addition, due to role changes after retirement and 
at older ages, patients feel more depressed to adapt to their new 
roles and living habits [41,50]. Patients without HF who have 
other illnesses, such as COAD, can face deteriorated physical 
health and ability, leading to more depression. COAD is a 
progressive respiratory disease that increases physical 
restriction and intolerance due to inadequate oxygenation. 
Receiving CRT-D can improve cardiac condition of patients 
but to patients without HF, receiving CRT-D induces higher 
risk of depression. Further investigation is needed. 
Considering ICD patients with HF on anxiety and 
depression, those who are more self-care dependent will 
perceive more anxiety. Patients with HF may need to have 
more assistance from others. The increase in dependence may 
induce more negative emotions due to low self-esteem and 
poor body image. Moreover, patients with HF who are of older 
age (≥60 years old), lower education level, are more self-care 
dependent, or are having DM perceive higher level of 
depression. ICD patients with HF who are more self-care 
dependent feel more depressed, which may be due to 
inadequate support [43]. Those with HF who have DM will be 
more depressed probably due to deterioration of general health 
condition. It is important to note that patients with HF having 
more self-care dependence will perceive more anxiety and 
depression.   
This study has some limitations. A cross-sectional design 
might not be able to provide the causal inference and 
information about the changes in psychological status and 
HRQoL in different periods for comparisons between two 
groups. Previous studies reported that ICD shock could lower 
HRQoL and increase psychological distress [26,51]. However, 
only a few patients in the two groups had ICD shock 
experience. Further study with a larger sample can be 
performed to understand more about ICD shock in ICD 
patients with and without HF. Therefore, predictors of 
psychological distress and HRQoL can be identified in a larger 
sample. 
VII.  CONCLUSION  
Psychological distress and poor HRQoL are major health 
concerns particularly while caring for cardiac patients. Since 
ICD patients both with and without HF are numbering, they 
can have different degrees of heightened psychological 
distress and poorer HRQoL. As caring for HF patients with 
ICD is a long-term endeavour, it is important for healthcare 
professionals to understand more about the differences of and 
possible factors correlated with psychological distress and 
HRQoL between ICD patients with and without HF. This 
study helps understand more about HRQoL and psychological 
distress as well as factors related to demographic and clinical 
characteristics between patient with and without ICD. 
Therefore, such results provide clear direction to develop and 
implement appropriate interventions targeting the possible 
factors to reduce psychological distress and improve HRQoL 
in ICD patients with different health needs, such as HF. 
Healthcare professionals can closely monitor the changes of 
psychological status and HRQoL by screening on a regular 
basis. Family involvement and adequate instructions may help 
improve patients’ self-care ability and adaptation to the new 
lifestyle of living with the device [13]. Psychological 
intervention [52,53] and cognitive behavioural intervention 
with appropriate coping strategies and stress management 
[54,55] can be implemented to reduce psychological distress 
and maximize HRQoL. 
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